Loading...
XNYSASH
Market cap3.25bUSD
Jan 10, Last price  
68.92USD
1D
-2.03%
1Q
-19.63%
Jan 2017
-36.94%
Name

Ashland Inc

Chart & Performance

D1W1MN
XNYS:ASH chart
P/E
19.24
P/S
1.54
EPS
3.58
Div Yield, %
2.40%
Shrs. gr., 5y
-4.52%
Rev. gr., 5y
-3.25%
Revenues
2.11b
-3.56%
9,860,000,0007,277,000,0007,834,000,0008,381,000,0008,106,000,0009,012,000,0006,502,000,0008,206,000,0007,813,000,0006,121,000,0005,387,000,0004,948,000,0003,260,000,0003,743,000,0002,493,000,0002,326,000,0002,111,000,0002,391,000,0002,191,000,0002,113,000,000
Net income
169m
-5.06%
2,004,000,000407,000,000230,000,000167,000,00071,000,000332,000,000414,000,00026,000,000683,000,000233,000,000309,000,000-29,000,0001,000,000114,000,00024,000,000-491,000,000173,000,000181,000,000178,000,000169,000,000
CFO
462m
+90.12%
10,000,000345,000,000195,000,000470,000,0001,025,000,000507,000,000245,000,000354,000,000733,000,000643,000,000334,000,000663,000,000365,000,000297,000,000241,000,000203,000,000560,000,000-213,000,000243,000,000462,000,000
Dividend
Aug 30, 20240.405 USD/sh
Earnings
Jan 28, 2025

Profile

Ashland Inc. provides additives and specialty ingredients worldwide. It operates through Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; and nutraceutical solutions comprising products for weight management, joint comfort, stomach and intestinal health, sports nutrition, and general wellness, as well as custom formulation, toll processing, and particle engineering solutions. The Personal Care & Household segment provides a range of nature-based, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. The Intermediates and Solvents segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical. The company was formerly known as Ashland Global Holdings Inc. Ashland Inc. was founded in 1924 and is based in Wilmington, Delaware.
URL
https://www.ashland.com/
IPO date
Mar 17, 1980
Employees
3,900
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑092023‑092022‑092021‑092020‑092019‑092018‑092017‑092016‑092015‑09
Income
Revenues
2,113,000
-3.56%
2,191,000
-8.36%
2,391,000
13.26%
Cost of revenue
1,954,000
1,939,000
2,009,000
Unusual Expense (Income)
NOPBT
159,000
252,000
382,000
NOPBT Margin
7.52%
11.50%
15.98%
Operating Taxes
(223,000)
(8,000)
25,000
Tax Rate
6.54%
NOPAT
382,000
260,000
357,000
Net income
169,000
-5.06%
178,000
-1.66%
181,000
4.62%
Dividends
(78,000)
(76,000)
(70,000)
Dividend yield
1.79%
1.72%
1.32%
Proceeds from repurchase of equity
(380,000)
(300,000)
(200,000)
BB yield
8.74%
6.80%
3.76%
Debt
Debt current
20,000
38,000
19,000
Long-term debt
1,567,000
1,548,000
1,477,000
Deferred revenue
Other long-term liabilities
839,000
818,000
900,000
Net debt
1,284,000
734,000
847,000
Cash flow
Cash from operating activities
462,000
243,000
(213,000)
CAPEX
(137,000)
(170,000)
(113,000)
Cash from investing activities
(102,000)
(109,000)
1,556,000
Cash from financing activities
(479,000)
(371,000)
(896,000)
FCF
706,000
127,000
248,000
Balance
Cash
300,000
417,000
646,000
Long term investments
3,000
435,000
3,000
Excess cash
197,350
742,450
529,450
Stockholders' equity
2,868,000
3,093,000
3,085,000
Invested Capital
4,977,650
4,630,550
5,020,550
ROIC
7.95%
5.39%
6.64%
ROCE
3.07%
4.56%
6.67%
EV
Common stock shares outstanding
50,000
54,000
56,000
Price
86.97
6.48%
81.68
-13.99%
94.97
6.56%
Market cap
4,348,500
-1.41%
4,410,720
-17.07%
5,318,320
-2.17%
EV
5,632,500
5,144,720
6,165,320
EBITDA
433,000
495,000
623,000
EV/EBITDA
13.01
10.39
9.90
Interest
43,000
6,000
62,000
Interest/NOPBT
27.04%
2.38%
16.23%